Bharat Biotech Commits to 1 Crore Worth Vaccines in Telangana
The pioneering Indian vaccine maker has now announced that it will be supplying Rs. 1 crore worth of vaccines in the Telangana region on its 20th year eve. The commitment letter was handed over to the Hon’ble Minister Shri. KT Rama Rao, Cabinet Minister for IT E&C, MAUD, Industries & Commerce, Mines & Geology, Public Enterprises and NRI Affairs, Government of Telangana.
The Genome Valley based biotech will be undertaking the distribution of Rotavac and TypbarTCV vaccines that have got global recognition and endorsement from World Health Organisation. Speaking at the logo launch, Rama Rao said, “Bharat has been instrumental in making Hyderabad a vaccine capital of the world. We will soon be having Genome Valley 2.0 to further strengthen our position in the global biotech destination.”
“Our journey began 20 years ago and we have demonstrated our expertise in all activities required for an integrated biotech company. Our focus is on preventing infectious diseases and to reduce its public health impact,” Dr. Krishna Ella said.
Since it began its operations 20 years ago at Genome Valley, Bharat Biotech has emerged as a trusted vaccine research, development & manufacturing partner to governments, public health agencies, healthcare providers, delivering at global scale with highest degree of indigenisation capabilities, and leveraging advancements in new molecule research.
Led by over 50 patents, a strong pipeline of vaccine brands that is accessible in over 100 countries Bharat Biotech is a uniquely integrated company that has built strong infrastructure to consolidate its leadership to make made in India vaccines for the world.
The announcement was made jointly with the company’s decision to renew its corporate logo.